BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15708201)

  • 41. Cognitive complaint in mild cognitive impairment and Alzheimer's disease.
    Clément F; Belleville S; Gauthier S
    J Int Neuropsychol Soc; 2008 Mar; 14(2):222-32. PubMed ID: 18282320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment.
    Levinoff EJ; Saumier D; Chertkow H
    Brain Cogn; 2005 Mar; 57(2):127-30. PubMed ID: 15708202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nondemented Parkinson disease patients: is cognitive performance associated with depressive difficulties?
    Klepac N; Trkulja V; Relja M
    Cogn Behav Neurol; 2008 Jun; 21(2):87-91. PubMed ID: 18541984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dementia following bipolar disorder].
    Lebert F; Lys H; Haëm E; Pasquier F
    Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment--proof of concept.
    Rolstad S; Nordlund A; Eckerström C; Gustavsson MH; Zetterberg H; Wallin A
    Dement Geriatr Cogn Disord; 2009; 27(2):194-200. PubMed ID: 19225233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impairment of episodic and semantic autobiographical memory in patients with mild cognitive impairment and early Alzheimer's disease.
    Leyhe T; Müller S; Milian M; Eschweiler GW; Saur R
    Neuropsychologia; 2009 Oct; 47(12):2464-9. PubMed ID: 19409401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive deficits in asymptomatic first-degree relatives of Alzheimer's disease patients.
    Hom J; Turner MB; Risser R; Bonte FJ; Tintner R
    J Clin Exp Neuropsychol; 1994 Aug; 16(4):568-76. PubMed ID: 7962359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
    Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
    Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonepisodic memory deficits in amnestic MCI.
    Economou A; Papageorgiou SG; Karageorgiou C; Vassilopoulos D
    Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Verbal and visuospatial deficits in dementia with Lewy bodies.
    Johnson DK; Morris JC; Galvin JE
    Neurology; 2005 Oct; 65(8):1232-8. PubMed ID: 16247050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive function and frontal lobe atrophy in normal elderly adults: Implications for dementia not as aging-related disorders and the reserve hypothesis.
    Meguro K; Shimada M; Yamaguchi S; Ishizaki J; Ishii H; Shimada Y; Sato M; Yamadori A; Sekita Y
    Psychiatry Clin Neurosci; 2001 Dec; 55(6):565-72. PubMed ID: 11737788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterogeneity of cognitive profiles in normal aging: implications for early manifestations of Alzheimer's disease.
    Mitrushina M; Uchiyama C; Satz P
    J Clin Exp Neuropsychol; 1995 May; 17(3):374-82. PubMed ID: 7650100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. WAIS-R intersubtest scatter in patients with dementia of Alzheimer's type.
    Mitrushina M; Drebing C; Satz P; Van Gorp W; Chervinsky A; Uchiyama C
    J Clin Psychol; 1994 Sep; 50(5):753-8. PubMed ID: 7806653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive deterioration in Alzheimer's disease: is the early course predictive of the later stages?
    Capitani E; Cazzaniga R; Francescani A; Spinnler H
    Neurol Sci; 2004 Oct; 25(4):198-204. PubMed ID: 15549505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Instability of cognitive asymmetry in Alzheimer's disease.
    Xeno Rasmusson D; Brandt J
    J Clin Exp Neuropsychol; 1995 May; 17(3):449-58. PubMed ID: 7650106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of education on cognitive performances and its implication for the constitution of the cognitive reserve.
    Le Carret N; Lafont S; Mayo W; Fabrigoule C
    Dev Neuropsychol; 2003; 23(3):317-37. PubMed ID: 12740188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associative recognition in Alzheimer's disease: evidence for impaired recall-to-reject.
    Gallo DA; Sullivan AL; Daffner KR; Schacter DL; Budson AE
    Neuropsychology; 2004 Jul; 18(3):556-63. PubMed ID: 15291733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.